Showing results (1-10 of 244) with videos related to
Sort By:
Pageof 25
Expert Opinion on Pharmacotherapy|May 9, 2017
Degarelix versus luteinizing hormone-releasing hormone agonists for the treatment of prostate cancerTimothy N Clinton, Solomon L Woldu, Ganesh V RajExpert Review of Precision Medicine and Drug Development|December 12, 2017
Tissue-based biomarkers in prostate cancerTimothy N Clinton, Aditya Bagrodia, Yair Lotan, et al.Current Opinion in Urology|July 14, 2018
Update on epidemiologic considerations and treatment trends in testicular cancerSolomon L Woldu, Aditya BagrodiaThe Urologic Clinics of North America|July 29, 2015
Reoperative Retroperitoneal Surgery: Etiology and Clinical OutcomeSolomon L Woldu, James M McKiernanExpert Review of Anticancer Therapy|April 1, 2017
Tackling non-muscle invasive bladder cancer in the clinicSolomon L Woldu, Öner Şanli, Yair LotanBJU International|January 7, 2017
Guideline of guidelines: non-muscle-invasive bladder cancerSolomon L Woldu, Aditya Bagrodia, Yair LotanCurrent Opinion in Urology|September 2, 2016
Testicular germ cell tumor genomicsSolomon L Woldu, James F Amatruda, Aditya BagrodiaCurrent Urology Reports|January 13, 2016
Renal Function Following Nephron Sparing Procedures: Simply a Matter of Volume?Michael J Biles, G Joel DeCastro, Solomon L WolduFrontiers in Oncology|June 2, 2012
Management of biochemical recurrence after primary localized therapy for prostate cancerOussama M Darwish, Ganesh V RajPageof 25